Cases of hepatitis C in the United States have nearly tripled within a five-year period, reaching a new 15-year high of around 34,000 new hepatitis C infections in 2015, federal health officials reported. Experts attribute the higher rates to more injection drug use during the ongoing opioid epidemic.
The new report from the U.S. Centers for Disease Control and Prevention (CDC) shows that cases of the disease rose substantially, from 850 new cases in 2010 to 2,436 cases in 2015. However, because most people with hepatitis C do not know they have the disease and most new infections go undiagnosed, the CDC estimates there were actually 34,000 new infections in 2015.
Hepatitis C testing and treatment is changing. Today, chronic HCV is usually curable with oral medications taken every day for two to six months. The largest group at risk includes everyone born between 1945 and 1965 — a population five times more likely to be infected than those born in other years; with the greatest number of new infections among young people from ages 20 to 29.
The new report from the U.S. Centers for Disease Control and Prevention (CDC) shows that cases of the disease rose substantially, from 850 new cases in 2010 to 2,436 cases in 2015. However, because most people with hepatitis C do not know they have the disease and most new infections go undiagnosed, the CDC estimates there were actually 34,000 new infections in 2015.
Hepatitis C testing and treatment is changing. Today, chronic HCV is usually curable with oral medications taken every day for two to six months. The largest group at risk includes everyone born between 1945 and 1965 — a population five times more likely to be infected than those born in other years; with the greatest number of new infections among young people from ages 20 to 29.
Join us on Monday, November 13, 2017, at the Beef Haus Restaurant, Upstairs Banquet Facility, North Main Street, Wellsville, New York, from 5:00-8:30p.m. for a Dinner Conference on Hepatitis C and Opioid Overdose Prevention.
Agenda 5:00p.m. Registration and Networking 5:30p.m. Dinner Buffet 6:00-7:30p.m. Professional Development Part 1 Treatment for Hepatitis C: New Tests, New Drugs, and New Recommendations Learning Objectives: 1. Explain the epidemiology of the hepatitis C virus (HCV). 2. Discuss laboratory testing and diagnosis of HCV infection. 3. Design a therapeutic regimen and monitoring plan for the treatment of HCV. 7:30-8:30p.m Professional Development Part 2 Naloxone: Preventing Opioid Overdose in the Community Learning Objectives: 1. Discuss the epidemiology of opioid overdose. 2. Identify how to avoid, recognize, and act on opioid overdoses. 3. Discuss the role and safety of prescribing and distributing naloxone. Cost: $20.00 Support by:
Ardent Solutions, Inc. Allegany County Opioid and Heroin Ad-Hoc Committee Allegany County Department of Health Partners for Prevention in Allegany County |
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based live activity “Treatment for Hepatitis C: New Tests, New Drugs, and New Recommendations,” ACPE #0044-9999-16-077-L01-P, will award 1.5 contact hours or .15 of pharmacy education credit. No partial credit will be awarded. This knowledge-based live activity “Naloxone: Preventing Opioid Overdose in the Community,” ACPE #0044-9999-16-056-L01-P, will award 1.0 contact hours or .10 of pharmacy education credit. No partial credit will be awarded. CME The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE The University at Albany School of Public Health is an Approved Provider of continuing nurse education by the Northeast Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This offering is approved for 1.0 nursing contact hours. |
Pre-registration is required by November 3, 2017, by calling Ardent Solutions at 585-593-1738 or by registering here.
